I don't think i would have invested in this company if I had foreseen the ineptitude of management.......the cash on hand is most worrying now and the time left is alarming. ..... How could PAR possibly have got into this predicament....Now we all rely on luck...and hope that the FDA will come back very soon with an approval to proceed phase 3 ...I wonder why they take so long to respond when we are designated fast track status.
PR has run this company very poorly and i wish I had not listened to Scott W on his advice to buy into the company.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-18
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.73M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 22.0¢ | $34.69K | 154.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28174 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 25000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |